TY - JOUR
T1 - Impact of Arrhythmias on Hospitalizations in Patients With Cardiac Amyloidosis
AU - Thakkar, Samarthkumar
AU - Patel, Harsh P.
AU - Chowdhury, Medhat
AU - Patel, Kirtenkumar
AU - Kumar, Ashish
AU - Arora, Shilpkumar
AU - Zahid, Salman
AU - Goel, Mishita
AU - Barssoum, Kirolos
AU - Jain, Vardhmaan
AU - AbouEzzeddine, Omar F.
AU - DeSimone, Christopher V.
AU - Baibhav, Bipul
AU - Rao, Mohan
AU - Deshmukh, Abhishek
N1 - Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2021/3/15
Y1 - 2021/3/15
N2 - Cardiac involvement in amyloidosis is associated with a poor prognosis. Data on the burden of arrhythmias in patients with cardiac amyloidosis (CA) during hospitalization are lacking. We identified the burden of arrhythmias using the National Inpatient Sample (NIS) database from January 2016 to December 2017. We compared patient characteristics, outcomes, and hospitalization costs between CA patients with and without documented arrhythmias. Out of 5,585 hospital admissions for CA, 2,020 (36.1%) had concurrent arrhythmias. Propensity-score matching for age, sex, income, and co-morbidities was performed with 1,405 CA patients with arrhythmias and 1,405 patients without. The primary outcome of all-cause mortality was significantly higher in CA patients with arrhythmia than without(13.9% vs 5.3%, p-value <0.001). Atrial fibrillation (AF) was the most common (72.2%) arrhythmia in CA patients with concurrent arrhythmia. The secondary outcomes of AF-related mortality (11.95% vs 9.16%, p-value = 0.02) and acute and acute on chronic as heart failure (HF) exacerbation (32.38% vs 24.91%, p-value <0.0001) were significantly higher in CA and concurrent arrhythmia compared with CA patients without. The total length of hospital stay (6[3 to 12] vs 5[3 to 10], p-value <0.001) and cost of hospitalization were ($ 15,086[7,813 to 30,373] vs $ 12,219[6,865 to 23,997], p-value = 0.001) were significantly greater among CA with arrhythmia compared with those without. These data suggest that the presence of arrhythmias in CA patients during hospital admission is associated with a poorer prognosis and may reflect patients with a higher risk of HF exacerbation and mortality.
AB - Cardiac involvement in amyloidosis is associated with a poor prognosis. Data on the burden of arrhythmias in patients with cardiac amyloidosis (CA) during hospitalization are lacking. We identified the burden of arrhythmias using the National Inpatient Sample (NIS) database from January 2016 to December 2017. We compared patient characteristics, outcomes, and hospitalization costs between CA patients with and without documented arrhythmias. Out of 5,585 hospital admissions for CA, 2,020 (36.1%) had concurrent arrhythmias. Propensity-score matching for age, sex, income, and co-morbidities was performed with 1,405 CA patients with arrhythmias and 1,405 patients without. The primary outcome of all-cause mortality was significantly higher in CA patients with arrhythmia than without(13.9% vs 5.3%, p-value <0.001). Atrial fibrillation (AF) was the most common (72.2%) arrhythmia in CA patients with concurrent arrhythmia. The secondary outcomes of AF-related mortality (11.95% vs 9.16%, p-value = 0.02) and acute and acute on chronic as heart failure (HF) exacerbation (32.38% vs 24.91%, p-value <0.0001) were significantly higher in CA and concurrent arrhythmia compared with CA patients without. The total length of hospital stay (6[3 to 12] vs 5[3 to 10], p-value <0.001) and cost of hospitalization were ($ 15,086[7,813 to 30,373] vs $ 12,219[6,865 to 23,997], p-value = 0.001) were significantly greater among CA with arrhythmia compared with those without. These data suggest that the presence of arrhythmias in CA patients during hospital admission is associated with a poorer prognosis and may reflect patients with a higher risk of HF exacerbation and mortality.
UR - http://www.scopus.com/inward/record.url?scp=85098499944&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85098499944&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2020.12.024
DO - 10.1016/j.amjcard.2020.12.024
M3 - Article
C2 - 33352208
AN - SCOPUS:85098499944
SN - 0002-9149
VL - 143
SP - 125
EP - 130
JO - American Journal of Cardiology
JF - American Journal of Cardiology
ER -